INGELHEIM, Germany - Friday, August 30th 2013
For media outside of the US, the UK & Canada only
What: Join key experts in cardiology and thrombosis for a special TweetChat (#ChatAFib), live from the ESC Congress 2013 (#ESCcongress2013) in Amsterdam, which is organised by the European Society of Cardiology
We will be discussing:
Key issues around awareness of cardiovascular disease and thrombosis in women
How common is antithrombotic treatment use in women versus men?
Are women more likely than men to become disabled by an AF-related stroke?
Management of women, cardiovascular disease and thrombosis in daily clinical practice
Who:
Prof. Angela Maas, Professor of Cardiology for Women, UMC, St. Radboud, The Netherlands
Dr. Yolande Appelman, Chair of the Working Group on Gender, The Netherlands Society of Cardiology and Interventional Cardiologist at VUmc
Patient Advocacy Group representatives including Mellanie True Hills from StopAFib.org and De Hart & Vaatgroep
When: 15:00 - 16:00 CET, Monday 2nd September
How: This is a bilingual TweetChat. To join the conversation in English follow #ChatAFib, to join the conversation in Dutch follow #Hartenvaat
On Twitter
Follow @boehringer and @boehringernl for updates and information
Contacts
Boehringer Ingelheim GmbH
Sara McClelland
Corporate Communications
Media + PR
Phone: +49 6132 – 77 8271
Fax: + 49 - 6132 – 72 6601
E-mail: press@boehringer-ingelheim.com
Twitter: http://twitter.com/Boehringer
More information
www.boehringer-ingelheim.com
Permalink: http://www.me-newswire.net/news/8364/en
No comments:
Post a Comment